BioSpace News Archive

At Pack Expo International 2022, Sepha will showcase its latest packaging and leak test innovations, including the VisionScan 3D, the Multi-Q HD and the EZ Blister+. Pack Expo International will be the first time that many of Sepha’s North American customers have the chance to see these new technologies on display together, as the company debuts its own dedicated booth themed around quality, integrity and reliability.

Trinity Biotech plc, a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter fiscal year 2022 on Thursday, November 3, 2022.

Cognitive Research Corporation a leading, full-service, therapeutically-focused Contract Research Organization specializing in the Central Nervous System sector, is pleased to announce that Jeff Williams has been appointed as Executive Chairman of the Board of Directors following the recent close of a growth equity investment from healthcare-focused private equity firm, RC Capital.

INVO Bioscience, Inc. (NASDAQ: INVO) today announced a successful showcasing of INVOcell at last week’s 2022 Scientific Congress & Expo of the American Society for Reproductive Medicine (ASRM) held on October 22-26, 2022 in Anaheim, California.

Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced a new research test for genitourinary pathogen and antimicrobial resistance identification.

SCA Pharma, a nationally recognized leader in the 503B compounded pharmaceuticals outsourcing industry, providing quality, service, and value to hospitals nationwide, has announced that Vizient has awarded a multi-year agreement to the company for its full range of 503B ready-to-use products.

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, today announced top-line clinical results for its Phase II COVID-19 “universal” booster vaccine, AKS-452.

Merz Aesthetics®, the world’s largest dedicated medical aesthetics business, today announced Teyana Taylor as the latest Xeomin® (incobotulinumtoxinA) brand partner.

The Global Congestive Heart Failure Drugs Market Size accounted for USD 7.15 billion in 2022 and is estimated to achieve a market size of USD 20.43 Billion by 2030 growing at a CAGR of 15.9% from 2022 to 2030.

Covalon Technologies Ltd., an advanced medical technologies company, announced that its newest advanced wound care product, ColActive Plus Powder, was showcased in a case study presentation at the Symposium on Advanced Wound Care, from October 13 to 16, 2022 in Las Vegas.